Results showed that LNCaP-TLX infectants exhibited no or negligible transactivation of ARE-luciferase reporter upon DHT treatment as compared to parental LNCaP cells, suggesting that overexpression of TLX could significantly suppress the AR transcription activity in prostate cancer cells (Fig. 5c). This evidence concerns the gene AR and prostate cancer.